• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血预处理可改变视网膜完全缺血时基因表达变化的模式。

Ischemic preconditioning alters the pattern of gene expression changes in response to full retinal ischemia.

作者信息

Kamphuis Willem, Dijk Frederike, Bergen Arthur A B

机构信息

Department of Molecular Ophthalmogenetics, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands.

出版信息

Mol Vis. 2007 Oct 5;13:1892-901.

PMID:17960128
Abstract

PURPOSE

Ischemic conditions in the retina have been implicated in several retinopathological conditions. Experimentally induced ischemia for 60 min followed by reperfusion leads to a loss of neurons in the inner retina. In contrast, a 5 min ischemic episode triggers a series of alterations that protect the retina against the damaging effects of a subsequent 60 min ischemic insult. This phenomenon is called ischemic preconditioning (IPC). To study the changes altered by IPC, we assessed the gene expression patterns in the rat retina after ischemia (60 min) followed by reperfusion (I/R) and compared these to the gene expression patterns after ischemia/reperfusion in preconditioned animals (IPC-I/R).

METHODS

Changes in gene expression were studied, by means of microarrays, at 1, 2, 6, and 12 h after I/R in naíve and preconditioned animals. To identify functional pathways of interest, we used significantly regulated genes as input for gene ontology analysis. Microarray results were validated by real-time quantitative PCR.

RESULTS

Most genes that were altered by I/R showed a comparable change in both naíve and preconditioned animals. Differential expression was found for a total of 1312 genes of the 20,280 features (6.4%) present on the array with a differential change of 1.7 fold or more. The list of genes with a differential change was characterized by a statistically significant overrepresentation of genes associated to the gene ontology terms tRNA aminoacylation (with a decreased expression due to preconditioning), immune response (with most genes upregulated), and apoptosis (mixed direction of changes). The results of quantitative PCR assays were in agreement with the microarray data.

CONCLUSIONS

The response of several functional groups of genes on ischemia was altered by a preconditioning stimulus. Most prominent differences were found for the group of genes encoding for aminoacyl-tRNA synthetases (ARSs), which is in line with the previously observed decreased expression of ARSs after induction of preconditioning. Our observations indicate that activation of translational activity may be a mediator of ischemia-associated damage in the retina, and IPC may prevent activation of this mechanism. An altered expression of genes implicated in immune response and in apoptosis may also be involved in effectuating IPC.

摘要

目的

视网膜缺血状态与多种视网膜病变有关。实验诱导的60分钟缺血再灌注会导致视网膜内层神经元丢失。相比之下,5分钟的缺血发作会引发一系列改变,保护视网膜免受随后60分钟缺血损伤的破坏作用。这种现象称为缺血预处理(IPC)。为了研究IPC改变的变化,我们评估了大鼠视网膜在缺血(60分钟)再灌注(I/R)后的基因表达模式,并将其与预处理动物(IPC-I/R)缺血/再灌注后的基因表达模式进行比较。

方法

通过微阵列研究了未预处理和预处理动物在I/R后1、2、6和12小时的基因表达变化。为了确定感兴趣的功能途径,我们使用显著调节的基因作为基因本体分析的输入。微阵列结果通过实时定量PCR进行验证。

结果

I/R改变的大多数基因在未预处理和预处理动物中显示出类似的变化。在阵列上存在的20280个特征中,共有1312个基因(6.4%)存在差异表达,差异变化为1.7倍或更大。差异变化的基因列表的特征是与基因本体术语tRNA氨酰化(由于预处理而表达降低)、免疫反应(大多数基因上调)和细胞凋亡(变化方向混合)相关的基因在统计学上显著过度表达。定量PCR分析结果与微阵列数据一致。

结论

预处理刺激改变了几组基因对缺血的反应。在编码氨酰-tRNA合成酶(ARSs)的基因组中发现了最显著的差异,这与之前观察到的预处理诱导后ARSs表达降低一致。我们的观察结果表明,翻译活性的激活可能是视网膜缺血相关损伤的介质,而IPC可能会阻止这种机制的激活。与免疫反应和细胞凋亡相关的基因表达改变也可能参与实现IPC。

相似文献

1
Ischemic preconditioning alters the pattern of gene expression changes in response to full retinal ischemia.缺血预处理可改变视网膜完全缺血时基因表达变化的模式。
Mol Vis. 2007 Oct 5;13:1892-901.
2
Global gene expression profiling of ischemic preconditioning in the rat retina.大鼠视网膜缺血预处理的全基因组表达谱分析。
Mol Vis. 2007 Jun 28;13:1020-30.
3
Mediators of rat ischemic hepatic preconditioning after cold preservation identified by microarray analysis.通过微阵列分析鉴定冷保存后大鼠缺血性肝预处理的介质。
Liver Transpl. 2006 Nov;12(11):1615-25. doi: 10.1002/lt.20863.
4
Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance.基于通路和基因本体论的脑缺血耐受大鼠模型基因表达分析
Brain Res. 2007 Oct 26;1177:103-23. doi: 10.1016/j.brainres.2007.07.047. Epub 2007 Aug 7.
5
The protective effect of ischemic preconditioning associated with altered gene expression profiles in intestinal grafts after reperfusion.缺血预处理与再灌注后肠道移植物中基因表达谱改变相关的保护作用。
J Surg Res. 2009 May 15;153(2):340-6. doi: 10.1016/j.jss.2008.06.002. Epub 2008 Jul 11.
6
The effect of cardiac ischemic preconditioning on rat left ventricular gene expression profile.心脏缺血预处理对大鼠左心室基因表达谱的影响。
Cell Biochem Funct. 2008 Mar-Apr;26(2):179-84. doi: 10.1002/cbf.1425.
7
Ischemic preconditioning attenuates apoptotic cell death in the rat retina.缺血预处理可减轻大鼠视网膜中的凋亡性细胞死亡。
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3059-66.
8
An immunocytochemical study on specific amacrine cell subpopulations in the rat retina after ischemia.大鼠视网膜缺血后特定无长突细胞亚群的免疫细胞化学研究
Brain Res. 2004 Nov 12;1026(2):205-17. doi: 10.1016/j.brainres.2004.08.014.
9
Genomic response of the rat brain to global ischemia and reperfusion.大鼠脑对全脑缺血和再灌注的基因组反应。
Brain Res. 2009 Feb 3;1252:1-14. doi: 10.1016/j.brainres.2008.10.045. Epub 2008 Oct 31.
10
Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion.缺血预处理和后处理对大鼠肝脏在缺血/再灌注后基因表达谱有显著影响。
Am J Physiol Gastrointest Liver Physiol. 2012 Aug 15;303(4):G482-9. doi: 10.1152/ajpgi.00337.2011. Epub 2012 Jun 7.

引用本文的文献

1
Remote Preconditioning Provides Protection Against Retinal Cell Death From Retinal Detachment.远程预处理可预防视网膜脱离导致的视网膜细胞死亡。
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):34. doi: 10.1167/iovs.66.2.34.
2
Adaptive Plasticity in the Retina: Protection Against Acute Injury and Neurodegenerative Disease by Conditioning Stimuli.视网膜中的适应性可塑性:通过条件刺激预防急性损伤和神经退行性疾病
Cond Med. 2018 Feb;1(2):85-97. Epub 2018 Feb 15.
3
Ischemic preconditioning inhibits over-expression of arginyl-tRNA synthetase gene Rars in ischemia-injured neurons.
缺血预处理可抑制缺血损伤神经元中精氨酰 - tRNA合成酶基因Rars的过度表达。
J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):554-557. doi: 10.1007/s11596-016-1624-5. Epub 2016 Jul 28.
4
Microarray analysis for differentially expressed genes of patients undergoing total knee arthroplasty with ischemia preconditioning.对接受缺血预处理的全膝关节置换术患者的差异表达基因进行微阵列分析。
J Orthop Surg Res. 2014;9(1):133. doi: 10.1186/s13018-014-0133-0. Epub 2014 Dec 12.
5
Human umbilical cord blood cells induce neuroprotective change in gene expression profile in neurons after ischemia through activation of Akt pathway.人脐带血细胞通过激活Akt信号通路,诱导缺血后神经元基因表达谱发生神经保护变化。
Cell Transplant. 2015;24(4):721-35. doi: 10.3727/096368914X685311. Epub 2015 Feb 26.
6
Time-dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina.时间依赖性基因谱分析表明视网膜缺血/再灌注损伤存在不同阶段。
Ophthalmol Eye Dis. 2014 Aug 25;6:43-54. doi: 10.4137/OED.S17671. eCollection 2014.
7
Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice.视网膜缺血/再灌注损伤后,小鼠基因表达的时间调控与进行性形态变化和视网膜功能障碍有关。
Mol Neurodegener. 2013 Jun 22;8:21. doi: 10.1186/1750-1326-8-21.
8
Changes in gene expression associated with retinal degeneration in the rd3 mouse.与rd3小鼠视网膜变性相关的基因表达变化。
Mol Vis. 2013 May 6;19:955-69. Print 2013.
9
Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning.视网膜缺血预处理中的丝裂原活化蛋白激酶磷酸酶-1(MKP-1)。
Exp Eye Res. 2011 Oct;93(4):340-9. doi: 10.1016/j.exer.2010.10.011. Epub 2010 Nov 20.
10
Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism.不同缺血条件下视网膜蛋白质组的变化——表观遗传调控机制的影响
Int J Physiol Pathophysiol Pharmacol. 2010 Jun 30;2(2):148-160.